About us

Driven by innovation and collaboration, we are reshaping the future of healthcare by advancing the accuracy of early skin cancer detection.



At bioflag.ai, we combine proprietary technology with artificial intelligence to push the boundaries of what's possible in cancer detection. Our pioneering approach aims to significantly outperform current smartphone-based solutions through a unique integration of natural science and advanced AI.



Based in Beverly Hills and collaborating with USC's dermatopathology lab, our team brings together world-class expertise in dermatology, artificial intelligence, and biotechnology. Led by Dr. Sameer Bashey and backed by proven innovators in healthcare technology, we're developing solutions that bridge the gap between advanced clinical diagnostics and accessible everyday screening.



Our work is driven by a simple truth: early detection saves lives. With melanoma survival rates dropping from 98% to 15% between early and late detection, we're committed to making accurate screening available to everyone, everywhere.